Post-Operative Pharmacologic Thromboprophylaxis after Major Hepatectomy

Journal of Gastrointestinal Surgery

Volumn 15, Issue 9, 2011, Pages 1602-1610

  Reddy, Srinevas K ^a   Turley, Ryan S ^b   Barbas, Andrew S ^b   Steel, Jennifer L ^a   Tsung, Allan ^a   Marsh, J Wallis ^a   Clary, Bryan M ^b   Geller, David A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Liver resection; Thromboprophylaxis; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; CHI SQUARE DISTRIBUTION; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATOCRIT; HUMAN; LIVER RESECTION; LUNG EMBOLISM; MALE; MIDDLE AGED; NONPARAMETRIC TEST; RETROSPECTIVE STUDY; RISK ASSESSMENT; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

ADULT; AGED; ANTICOAGULANTS; CHI-SQUARE DISTRIBUTION; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATOCRIT; HEPARIN, LOW-MOLECULAR-WEIGHT; HEPATECTOMY; HUMANS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 80051930602     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-011-1591-x     Document Type: Article

References (54)

1. Turpie AGG, Bauer KA, Caprini JA, Comp JS, Gent M, Muntz JE, Apollo Investigators. Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. J Thromb and Haemost 2007; 5: 1854-61.
2. Mismetti P, Laporte S, Darmon JY, Buchmuller A, Decousus H. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 2001; 88: 913-30.
3. Samana CM, Albaladejo P, Benhamou D, Bertin-Maghit M, Bruder N, Doublet JD, Laversin S, Leclerc S, Marret E, Mismetti P, Samain E, Steib A. Venous thromboembolism prevention in surgery and obstetrics: clinical practice guidelines. Eur J Anaesth 2006; 23: 95-116.
4. Collins R, Scrimgeour A, Yusuf S. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopedic, and urologic surgery. NEJM 1988; 318: 1162-73.
5. Clagett GP, Reisch JS. Prevention of venous thromboembolism in general surgical patients: results of meta-analysis. Ann Surg 1988; 208: 227-240.
6. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines, 8th edition. Chest 2008; 133: 381S-453S.
7. Koch A, Ziegler S, Breitschwerdt H, Victor N. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis: meta-analysis based on original patient data. Thromb Res 2001; 102: 295-309.
8. Leonardi MJ, McGory ML, Ko CY. A systematic review of deep venous thrombosis prophylaxis in cancer patients: implications for improving quality. Ann Surg Oncol 2007; 14: 929-36.
9. Agnelli G, Bolis G, Capussotti L, Scarpa RM, Tonelli F, Bonizzoni E, Moia M, Parazzini F, Rossi R, Sonaglia F, Valarani B, Bianchini C, Gussoni G. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg 2006; 243: 89-95.
10. Bergovist D, Agnelli G, Cohen AT, Eldor A, Nilsson PE, Le Moigne-Amrani A, Dietrich-Neto F. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. NEJM 2002; 346: 975-80.
11. Stanley A, Young A. Primary prevention of venous thromboembolism in medical and surgical oncology patients. Br J Cancer 2010; 102: S10-6.
12. Petersen LJ. Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: a review of current guidelines. Cancer Treatment Rev 2009; 35: 754-64.
13. Stashenko G, Lopes RD, Garcia D, Alexander JH, Tapson VF. Prophylaxis for venous thromboembolism: guidelines translated for the clinician. J Thromb Thrombolysis 2011; 31: 122-32.
14. The Joint Commission Web site. Venous thromboembolism (VTE) Core Measurement Set. http://www. jointcommission. org/assets/1/6/Venous%20Thromboembolism. pdf Accessed December 19, 2010.
15. National Quality Forum. NQF-Endorsed Voluntary Consensus Standards for Hospital Care. http://www. qualityforum. org/Publications/2006/12/National_Voluntary_Consensus_Standards_for_Prevention_and_Care_of_Venous_Thromboembolism_Policy,_Preferred_Practices,_and_Initial_Performance_Measures. aspx. Accessed December 19, 2010.
16. Department of Health and Human Services, Agency for Health-care Research and Quality. Patient safety indicators. http://www. qualityindicators. ahrq. gov/downloads/psi/2006-Feb-PatientSafetyIndicators. pdf.
17. Centers for Medicare and Medicaid Services. Hospital-Acquired Conditions. http://www1. cms. gov/hosptialacqcond/. Accessed December 19, 2010.
18. The Medicare Quality Improvement Community Web site. Patient safety quality measures for the Surgical Care Improvement Project. https://www. qualitynet. org/dcs/ContentServer?c=MQTools&pagename=Medqic%2FMQTools%2FToolTemplate&cid=1228733278547. Accessed December 19, 2010.
19. Blom JW, Vanderschoot JPM, Oostinidier MJ, Osanto S, van der Meer FJ, Rosendaal FR. Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: results of a record linkage study. J Thromb Haemost 2006; 4: 529-35.
20. Chew HK, Wun T, Harvey D, Zhou H, White RH. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 2006; 166: 458-64.
21. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3 rd. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000; 160: 809-15.
22. Blom JW, Doggen CJM, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005; 293: 715-22.
23. Kakkar AK, Haas S, Wolf H, Encke A. Evaluation of perioperative fatal pulmonary embolism and death in cancer surgical patients. Thromb Haemost 2005; 94: 867-71.
24. Enoxacan Study Group. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicenter trial with venographic assessment. Br J Surg 1997; 84: 1099-103.
25. Stein PD, Beemath A, Meyers FA, Skaf E, Sanchez J, Olson RE. Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med 2006; 119: 60-8.
26. Cronin-Fenton DP, Sondergaard F, Pedersen LA, Fryzek JP, Cetin K, Acquavella J, Baron JA, Sorensen HT. Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006. Br J Cancer 2010; 103: 947-53.
27. Kakkar AK, Levine M, Pinedo HM, Wolff R, Wong J. Venous thrombosis in cancer patients: insights from the FRONTLINE survey. Oncologist 2003; 8: 381-8.
28. Strasberg SM. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobil Pancreat Surg 2005; 13: 351-5.
29. Dindo D, DeMartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-13.
30. Reddy SK, Barbas AS, Turley RS, Steel JL, Tsung A, Marsh JW, Geller DA, Clary BM. A standard definition of major hepatectomy: resection of four or more liver segments. HPB, in press.
31. De Pietri L, Montalti R, Begliomini B, Scaglioni G, Marconi G, Reggiani A, Di Benedetto F, Aiello S, Pasetto A, Rompianesi G, Gerunda GE. Thromboelastographic changes in liver and pancreatic cancer surgery: hypercoagulability, hypocoagulability or normocoagulability? Eur J Anaesthesiol 2010; 27: 608-16.
32. Bezeaud A, Denninger MH, Dondero F, Saada V, Venisse L, Huisse MG, Belghiti J, Guillin MC. Hypercoagulability after partial liver resection. Thromb Haemost 2007; 98: 1252-6.
33. Senzolo M, Sartori MT, Lisman T. Should we give thromboprophylaxis to patients with liver cirrhosis and coagulopathy? HPB 2009; 11: 459-64.
34. Dondero F, Farges O, Belghiti J, Francoz C, Sommacale D, Durand F, Sauvanet A, Janny S, Varma D, Vilgrain V. A prospective analysis of living-liver donation shows a high rate of adverse events. J Hepatobil Pancreat Surg 2006; 13: 117-22.
35. Dondero F, Taille' C, Mal H, Sommacale D, Sauvanet A, Farges O, Francoz C, Durand F, Delefosse D, Denninger MH, Vilgrain V, Marrash-Chahla R, Fournier M, Belghiti J. Respiratory complications: a major concern after right hepatectomy in living liver donors. Transplantation 2006; 81: 181-6.
36. Aloia TA, Fahy BN, Fischer CP, Jones SL, Duchini A, Galati J, Gaber AO, Ghobrial RM, Bass BL. Predicting poor outcome following hepatectomy: analysis of 2313 hepatectomies in the NSQIP database. HPB 2009; 11: 510-5.
37. Schroeder RA, Marroquin CE, Bute BP, Khuri S, Henderson WG, Kuo PC. Predictive indices of morbidity and mortality after liver resection. Ann Surg 2006; 243: 373-9.
38. Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, Corvera C, Weber S, Blumgart LH. Improvement in perioperative outcome after hepatic resection: analysis of 1, 803 consecutive cases over the past decade. Ann Surg 2002; 236: 397-406.
39. Ito H, Are C, Gonen M, D'Angelica M, DeMatteo RP, Kemeny NE, Fong Y, Blumgart LH, Jarnagin WR. Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer. Ann Surg 2008; 247: 994-1002.
40. Morris-Stiff G, White D, Gomez G, Toogood G, Lodge JP, Prasad KR. Thrombotic complications following liver resection for colorectal metastases are preventable. HPB 2008; 10: 311-4.
41. Stewart GD, O'Suillebhain CB, Madhavan KK, Wigmore SJ, Parks RW, Garden OJ. The extent of resection influences outcome following hepatectomy for colorectal liver metastases. EJSO 2004; 30: 370-6.
42. Yates TJ, Abouljoud M, Lambing A, Kuriakose P. Risk of venous thrombosis in patients with hepatic malignancies undergoing surgical resection. Indian J Gastroenterol 2008; 27: 159-61.
43. Lo CM. Complications and long-term outcome of living liver donors: a survey of 1508 cases in five Asian centers. Transplantation 2003; 75: S12-5.
44. Broering DC, Wilms C, Bok P, Fischer L, Mueller L, Hillert C, Lenk C, Kim JS, Sterneck M, Schulz KH, Krupski G, Nierhaus A, Ames D, Burdelski M, Rogiers X. Evolution of donor morbidity in living related liver transplantation: a single center analysis of 165 cases. Ann Surg 2004; 240: 1013-26.
45. Marsh JW, Gray E, Ness R, Starzl TE. Complications of right lobe living donor liver transplantation. J Hepatol 2009; 51: 715-24.
46. Umeshita K, Fujiwara K, Kiyosawa K, Makuuchi M, Satomi S, Sugimachi K, Tanaka K, Monden M. Operative morbidity of living liver donors in Japan. Lancet 2003; 362: 687-90.
47. Cerutti E, Stratta C, Romagnoli R, Schellino MM, Skurzak S, Rizzetto M, Tamponi G, Salizzoni M. Thromboelastogram monitoring in the perioperative period of hepatectomy for adult living liver donation. Liver Transpl 2004; 10: 289-94.
48. Northup PG, McMahon MM, Ruhl AP, Altschuler SE, Volz-Bednarz A, Caldwell SH, Berg CL. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. Am J Gastroenterol 2006; 101: 1524-8.
49. Lizarraga WA, Dalia S, Reinert SE, Schiffman FJ. Venous thrombosis in patients with chronic liver disease. Blood Coagul Fibrinol 2010; 21: 431-5.
50. Dabbagh O, Oza A, Prakash S, Sunna R, Saettele TM. Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease. Chest 2010; 137: 1145-9.
51. Sogaard KK, Horvath-Puho E, Gronbaek H, Jepsen P, Vilstrup H, Sorensen HT. Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastroentol 2009; 104: 96-101.
52. Nothrup PG, Sundaram V, Fallon MB, Reddy KR, Balogun RA, Sanyal AJ, Anstee QM, Hoffman MR, Ikura Y, Caldwell SH. Hypercoagulation and thrombophilia in liver disease. J Thromb Haemost 2007; 6: 2-9.
53. Gulley D, Teal E, Suvannasankha A, Chalasani N, Liangpunsakul S. Deep vein thrombosis and pulmonary embolism in cirrhosis patients. Dig Dis Sci 2008; 53: 3012-7.
54. Kotronen A, Joutsi-Korhonen L, Sevastianova K, Bergholm R, Hakkarainen A, Pietilainen KH, Lundbom N, Rissanen A, Lassila R, Yki-Jarvinen H. Increased coagulation factor VIII, IX, XI, and XII activities in non-alcoholic fatty liver disease. Liver Int 2011; 31: 176-83.